Compound Detail
CHEMBL95224
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL95224 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RQXHJSQFAREWIS-WBVHZDCISA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
328.4
MW (Da)
3.38
ALogP
5
HBA
0
HBD
49.5
PSA (Ų)
0.81
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 7.21
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| KB | IC50 | = | 62.0 | nM | 7.21 | The compound was tested for its cytotoxic concentration required to inhibit the ... | 12270161 |
| KB | IC50 | = | 62.0 | nM | 7.21 | The compound was tested for its cytotoxic concentration required to inhibit the ... | 12270161 |
| 1A9 | IC50 | = | 82.0 | nM | 7.09 | Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined | 12270161 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12270161 | 10.1016/s0960-894x(02)00635-2 | KB | 2 |
| 12270161 | 10.1016/s0960-894x(02)00635-2 | A9 | 2 |
| 12270161 | 10.1016/s0960-894x(02)00635-2 | 1A9 | 1 |
Data from ChEMBL 36 via Core Engine